EUVIMEDEUVIMED entdecken
Crossref

CRISPR/Cas14a-SNPT: An engineered sgRNA mismatch-enabled platform for ultrasensitive SNP typing in hereditary G6PD deficiency

Luwei Chai, Xinge Cui, Qisi Xu, Chenxi Li, Yong Xie, Keya Tong, Tao Le

Biosensors and Bioelectronics · 2027

DOI: 10.1016/j.bios.2026.119217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2027. Verfasst von Luwei Chai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Animal Biology Key Laboratory of Chongqing Education Commission of China, College of Life Sciences, Chongqing Normal University, Chongqing, 401331, C…. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, CRISPR-Cas Systems, Glucosephosphate Dehydrogenase, Biosensing Techniques. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Chongqing Municipal Education Commission, Science Health Joint Medical Scientific Research Project of Chongqing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single-nucleotide polymorphism (SNP) detection plays a critical role in early screening and genotyping of genetic diseases. In this study, hereditary glucose-6-phosphate dehydrogenase (G6PD) deficiency was used as a model to develop a CRISPR/Cas14a-based SNP genotyping platform (CRISPR/Cas14a-SNPT). The platform integrates recombinase polymerase amplification (RPA) signal amplification with optimized sgRNA design. By introducing a shortened optimized sgRNA (op-sgRNA) to enhance Cas14a activity, together with engineered sgRNA mismatch regulation, the system enables rapid, highly sensitive, and high-resolution SNP detection. The results demonstrated a limit of detection of 1 copy/μL for plasmid templates, and reliable discrimination of variant allele frequencies as low as 0.1%. In clinical validation, the method successfully identified three hotspot mutations (c.95A > G, c.1388G > A, and c.1376G > T) in 13 human blood samples, showing excellent agreement with pyrosequencing results. Furthermore, molecular dynamics simulations revealed the regulatory mechanism of Cas14a mismatch recognition at the molecular level, suggesting that additional mismatches induce duplex relaxation and structural compensation effects, thereby enhancing target discrimination specificity. This study provides an efficient and practical strategy for accurate genotyping and prenatal carrier screening of G6PD deficiency-associated SNPs, demonstrating strong potential for rapid detection of clinically relevant SNPs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymorphism, Single NucleotideCRISPR-Cas SystemsGlucosephosphate DehydrogenaseBiosensing TechniquesHumansGenotyping TechniquesRNA, Guide, CRISPR-Cas SystemsNucleic Acid Amplification TechniquesGene FrequencyBase Pair Mismatch

Stichwörter der Autor:innen

CRISPR/Cas14aG6PD deficiencyGenotypingRecombinase polymerase amplification (RPA)Single nucleotide polymorphism (SNP)sgRNA mismatch engineering

Substanzen

Glucosephosphate DehydrogenaseRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Animal Biology Key Laboratory of Chongqing Education Commission of China, College of Life Sciences, Chongqing Normal University, Chongqing, 401331, China.
  • Chongqing Extended Reality Intelligent Connection Health Monitoring Technology Promotion Center, Chongqing Polytechnic University of Electronic Technology, Chongqing, 401331, China.
  • Center for Reproductive Medicine, Chongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, Chongqing, 400016, China. Electronic address: tongkeya123@163.com.
  • Animal Biology Key Laboratory of Chongqing Education Commission of China, College of Life Sciences, Chongqing Normal University, Chongqing, 401331, China. Electronic address: letao@cqnu.edu.cn.

Förderung

  • Chongqing Municipal Education Commission
  • Science Health Joint Medical Scientific Research Project of Chongqing

Zitieren

APA

Chai, L., Cui, X., Xu, Q., Li, C., Xie, Y., Tong, K., & Le, T. (2027). CRISPR/Cas14a-SNPT: An engineered sgRNA mismatch-enabled platform for ultrasensitive SNP typing in hereditary G6PD deficiency. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119217

Vancouver

Chai L, Cui X, Xu Q, Li C, Xie Y, Tong K, et al. CRISPR/Cas14a-SNPT: An engineered sgRNA mismatch-enabled platform for ultrasensitive SNP typing in hereditary G6PD deficiency. Biosensors and Bioelectronics. 2027. doi:10.1016/j.bios.2026.119217

BibTeX
@article{Chai2027,
  author = {Chai, Luwei and Cui, Xinge and Xu, Qisi and Li, Chenxi and Xie, Yong and Tong, Keya and Le, Tao},
  title = {CRISPR/Cas14a-SNPT: An engineered sgRNA mismatch-enabled platform for ultrasensitive SNP typing in hereditary G6PD deficiency},
  journal = {Biosensors and Bioelectronics},
  year = {2027},
  doi = {10.1016/j.bios.2026.119217}
}
Kostenlos starten →